Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 The High-Stakes Nature of Nitrosamine Impurities in APIs | Contract Pharma

What are you searching for?

Sign in
White Papers / Tech Papers

The High-Stakes Nature of Nitrosamine Impurities in APIs

Nitrosamines are a group of chemical compounds known for their carcinogenic properties.

Released By Solvias

Nitrosamines are a group of chemical compounds known for their carcinogenic properties. These compounds can unintentionally form as impurities during the manufacturing of various substances, including active pharmaceutical ingredients (APIs). With the FDA and global health authorities strengthening regulatory requirements after several prominent recalls of widely used medications, the spotlight on nitrosamines has intensified. For pharmaceutical companies, the stakes are high. The presence of nitrosamines in drug products on the market can trigger recalls, causing severe financial and reputational damage. Moreover, during the approval process of a new drug, insufficient data on nitrosamines can lead to costly delays. Proactively managing nitrosamine risks is an imperative for drug developers to ensure compliance with regulations, maintain product safety, and uphold public trust.

Download White Papers / Tech Papers Now

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters